Aripiprazole
Aripiprazole is a pharmaceutical drug with 245 clinical trials. Currently 4 active trials ongoing. Historical success rate of 86.1%.
Success Metrics
Based on 179 completed trials
Phase Distribution
Phase Distribution
17
Early Stage
24
Mid Stage
169
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
82.5%
179 of 217 finished
17.5%
38 ended early
4
trials recruiting
245
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Study of Aripiprazole in the Treatment of Serious Behavioral Problems in Children and Adolescents With Autistic Disorder (AD)
Biomarkers to Enhance Early Schizophrenia Treatment
Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of Schizophrenia and to Evaluate the Relapse Rate of Roluperidone and Antipsychotic Medications
A Switch Study of BMS-337039 in Schizophrenic Out-patients
Comparative Effectiveness Research Trial for Antidepressant Incomplete and Non-responders With TRD
Clinical Trials (245)
Study of Aripiprazole in the Treatment of Serious Behavioral Problems in Children and Adolescents With Autistic Disorder (AD)
Biomarkers to Enhance Early Schizophrenia Treatment
Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of Schizophrenia and to Evaluate the Relapse Rate of Roluperidone and Antipsychotic Medications
A Switch Study of BMS-337039 in Schizophrenic Out-patients
Comparative Effectiveness Research Trial for Antidepressant Incomplete and Non-responders With TRD
Aripiprazole Pharmacokinetics (PK) and Tolerability Study in Children and Adolescents
Cerebellum-based Imaging Neural Markers for Antipsychotic Response
Switching Medication to Treat Schizophrenia
Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD)
Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD).
A Study Assessing the Efficacy and Safety of HS-10380 in Hospitalized Adults With Acute Schizophrenia
Substance Misuse To Psychosis for Stimulants
Sequenced Treatment Alternatives to Relieve Adolescent Depression (STAR-AD)
Atypical Antipsychotic-induced Mitochondrial Dysfunction in Patients With Schizophrenia
Aripiprazole in Body Focused Repetitive Behaviors
Whole Blood and Plasma Sample Collection for the Development of Antipsychotic Immunoassays From Participants Taking Aripiprazole, Olanzapine, Paliperidone, or Risperidone
RP5063 in Subjects With Schizophrenia or Schizoaffective Disorder
Switching Medication and Augmentation Strategies for SSRI-Resistant Adolescent Depression(SMART-I)
A Study to Compare Disease Progression and Modification Following Treatment With Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics in Participant's With Recent-onset Schizophrenia or Schizophreniform
Safety and Efficacy of Brexpiprazole in the Treatment of Schizophrenia
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 245